Related Experiment Video
Updated: Jun 14, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001
Gyungtae Chung1, Jeongok Cha, Sunyoung Han
1Division of Antimicrobial Resistance, Center for Infectious Disease, National Institute of Health, Seoul 122-701, Korea.
Abstract:
We investigated the prevalence and the molecular characteristics of vancomycin-intermediate Staphylococcus aureus (VISA) among methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 8-week period in each year from 2001 to 2006. Of 41,639 MRSAs isolated, 37,856 were screened and 169 grew on brain heart infusion agar supplemented with 4 microg/ml vancomycin. A vancomycin MIC of 4 microg/ml was confirmed for 33 VISA isolates of the 169 isolates. Eighteen of the 33 isolates were classified as hetero-VISA (hVISA) by the population analysis profile (PAP) method. All VISA isolates were susceptible to linezolid, tigecycline, and quinupristin-dalfopristin. Most VISA isolates (MIC 4 microg/ml) showed a PFGE C pattern with sec, seg, and sei enterotoxin genes, including ST5-SCCmec type II, or a PFGE A pattern with sea, including ST239-SCCmec type III.
Insights
We found vancomycin-intermediate Staphylococcus aureus (VISA) in 33 strains among 41,639 methicillin-resistant Staphylococcus aureus (MRSA) isolates in Korea. These VISA strains remained susceptible to newer antibiotics like linezolid.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat.
- The emergence of vancomycin resistance in MRSA, including vancomycin-intermediate Staphylococcus aureus (VISA), complicates treatment options.
- Nationwide surveillance is crucial for monitoring antimicrobial resistance patterns.
Purpose of the Study:
- To determine the prevalence of VISA among MRSA isolates in Korean hospitals.
- To characterize the molecular features of identified VISA strains.
- To assess the susceptibility of VISA isolates to alternative antibiotics.
Main Methods:
- A nationwide surveillance program screened MRSA isolates from clinical samples between 2001 and 2006.
- Isolates were screened using brain heart infusion agar with 4 µg/ml vancomycin.
- Vancomycin Minimum Inhibitory Concentration (MIC) and population analysis profile (PAP) methods were used for confirmation and hetero-VISA (hVISA) classification.
Main Results:
- Out of 41,639 MRSA isolates, 169 showed growth on selective media, and 33 were confirmed as VISA (MIC = 4 µg/ml).
- Eighteen of the 33 VISA isolates were further classified as hVISA using the PAP method.
- All confirmed VISA isolates were susceptible to linezolid, tigecycline, and quinupristin-dalfopristin.
Conclusions:
- VISA represents a low but present threat within the MRSA population in Korean clinical settings.
- Molecular characterization revealed specific PFGE patterns and enterotoxin gene profiles in VISA isolates.
- The susceptibility of VISA to newer agents suggests potential alternative therapeutic options.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Automated Microbial Diagnostics
Antimicrobial Effectiveness